S.C. Ropharma S.A. (BVB: RPH)
Romania
· Delayed Price · Currency is RON 0.172
-0.004 (-2.27%)
At close: Dec 18, 2024
S.C. Ropharma Income Statement
Financials in millions RON. Fiscal year is January - December.
Millions RON. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 1,064 | 1,006 | 912.74 | 776.69 | 716.27 | 720.21 | Upgrade
|
| Other Revenue | 123.31 | 113.83 | 89.23 | 111.47 | 89.58 | 63.5 | Upgrade
|
| Revenue | 1,187 | 1,120 | 1,002 | 888.16 | 805.85 | 783.71 | Upgrade
|
| Revenue Growth (YoY) | 10.06% | 11.80% | 12.81% | 10.21% | 2.83% | 23.18% | Upgrade
|
| Cost of Revenue | 916.19 | 866.05 | 788.1 | 686.93 | 625.55 | 628.44 | Upgrade
|
| Gross Profit | 270.69 | 254.14 | 213.88 | 201.23 | 180.31 | 155.27 | Upgrade
|
| Selling, General & Admin | 197.53 | 184.61 | 156.95 | 142.62 | 124.74 | 112.05 | Upgrade
|
| Other Operating Expenses | 25.15 | 22.86 | 23.88 | 18.34 | 22.32 | 15.8 | Upgrade
|
| Operating Expenses | 249.6 | 234.12 | 204.62 | 184.12 | 169.75 | 146.57 | Upgrade
|
| Operating Income | 21.09 | 20.02 | 9.26 | 17.11 | 10.55 | 8.7 | Upgrade
|
| Interest Expense | -5.95 | -5.56 | -3.44 | -3.21 | -3.26 | -2.74 | Upgrade
|
| Interest & Investment Income | 0.1 | 0.08 | 0.03 | 0.24 | 0.03 | 0.02 | Upgrade
|
| Currency Exchange Gain (Loss) | -1.84 | -2.08 | -0.25 | -2.43 | -2.35 | -3.27 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.3 | 0.46 | 0.75 | 0.27 | -0 | - | Upgrade
|
| EBT Excluding Unusual Items | 13.69 | 12.91 | 6.35 | 11.99 | 4.97 | 2.71 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.54 | 0.18 | 2.81 | 0.95 | 0.03 | 0.21 | Upgrade
|
| Asset Writedown | 0.6 | 0.6 | 1.16 | 0.6 | 1.64 | 3.76 | Upgrade
|
| Pretax Income | 14.83 | 13.69 | 10.32 | 13.53 | 6.64 | 6.69 | Upgrade
|
| Income Tax Expense | 9.89 | 2.01 | 2.82 | 1.96 | 2 | 1.99 | Upgrade
|
| Earnings From Continuing Operations | 4.94 | 11.68 | 7.49 | 11.57 | 4.64 | 4.69 | Upgrade
|
| Minority Interest in Earnings | -4.9 | -3.96 | 1.72 | -0.84 | 2.12 | 2.83 | Upgrade
|
| Net Income | 0.04 | 7.72 | 9.22 | 10.73 | 6.75 | 7.52 | Upgrade
|
| Net Income to Common | 0.04 | 7.72 | 9.22 | 10.73 | 6.75 | 7.52 | Upgrade
|
| Net Income Growth | -99.65% | -16.25% | -14.10% | 58.86% | -10.23% | -37.93% | Upgrade
|
| Shares Outstanding (Basic) | 516 | 511 | 511 | 511 | 510 | 510 | Upgrade
|
| Shares Outstanding (Diluted) | 516 | 511 | 511 | 511 | 510 | 510 | Upgrade
|
| Shares Change (YoY) | 0.90% | - | - | 0.30% | -0.00% | -0.18% | Upgrade
|
| EPS (Basic) | 0.00 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | Upgrade
|
| EPS (Diluted) | 0.00 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | Upgrade
|
| EPS Growth | -99.65% | -16.25% | -14.11% | 58.38% | -10.22% | -37.82% | Upgrade
|
| Free Cash Flow | 25.96 | 24.33 | 11.88 | 21.53 | -20.68 | -28.37 | Upgrade
|
| Free Cash Flow Per Share | 0.05 | 0.05 | 0.02 | 0.04 | -0.04 | -0.06 | Upgrade
|
| Gross Margin | 22.81% | 22.69% | 21.35% | 22.66% | 22.37% | 19.81% | Upgrade
|
| Operating Margin | 1.78% | 1.79% | 0.92% | 1.93% | 1.31% | 1.11% | Upgrade
|
| Profit Margin | 0.00% | 0.69% | 0.92% | 1.21% | 0.84% | 0.96% | Upgrade
|
| Free Cash Flow Margin | 2.19% | 2.17% | 1.19% | 2.42% | -2.57% | -3.62% | Upgrade
|
| EBITDA | 31.7 | 36.2 | 24.18 | 31.36 | 25.2 | 18.89 | Upgrade
|
| EBITDA Margin | 2.67% | 3.23% | 2.41% | 3.53% | 3.13% | 2.41% | Upgrade
|
| D&A For EBITDA | 10.61 | 16.18 | 14.92 | 14.25 | 14.65 | 10.19 | Upgrade
|
| EBIT | 21.09 | 20.02 | 9.26 | 17.11 | 10.55 | 8.7 | Upgrade
|
| EBIT Margin | 1.78% | 1.79% | 0.92% | 1.93% | 1.31% | 1.11% | Upgrade
|
| Effective Tax Rate | 66.71% | 14.69% | 27.38% | 14.48% | 30.15% | 29.82% | Upgrade
|
| Revenue as Reported | 1,189 | 1,122 | 1,005 | 890.27 | 810.89 | 788.92 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.